Search clinical trials for: Apremilast and Clobetasol

Total 271745 results

Leon Kircik, M.D.
Stiefel, a GSK Company

Completed

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis

Psoriasis

United States
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Withdrawn

Apremilast Therapy for Acute Gouty Arthritis

Acute Gout

United States
Can-Fite BioPharma

Completed

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

Israel, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
Second Affiliated Hospital, School of Medicine,...

Recruiting

EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs

Stroke, Acute Ischemic

China
Virginia Clinical Research, Inc.
Celgene Corporation

Unknown

Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus

Lichen Planus

United States
Sir Charles Gairdner Hospital
The University of Western Australia

Terminated

The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients

Peritoneal Dialysis | Peritoneal Dialysis, Continuous Ambulatory

Australia
National Institutes of Health Clinical Center (CC)

Completed

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Thrombosis

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke

Cerebrovascular Stroke

Spain
Novo Nordisk A/S

Completed

Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Medtronic Neurovascular Clinical Affairs

Completed

Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial (SWIFT PRIME)

Acute Ischemic Stroke

United States
VA Office of Research and Development
University Hospitals Cleveland Medical Center

Terminated

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

Psoriasis

United States
Tufts Medical Center
Celgene Corporation

Completed

Study of Apremilast in Atopic or Contact Dermatitis

Atopic Dermatitis | Allergic Contact Dermatitis

United States
Odense University Hospital
LEO Pharma; University of Southern Denmark

Unknown

Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation (WA+TR_1)

Dermatitis, Contact | Dermatitis, Occupational

Denmark
Novo Nordisk A/S

Completed

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Norway, Sweden
Medical College of Wisconsin
Mayo Clinic; Seattle Children's Hospital; University of Toronto

Withdrawn

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Scleroderma
Oslo University Hospital
Celgene Corporation; Amgen

Active, not recruiting

The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

Lichen Planus of Vulva | Female Genital Disease

Norway
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
Bayer

Completed

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Psoriasis

Germany
Derm Research, PLLC

Unknown

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Psoriasis

United States
Technische Universität Dresden

Completed

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound (OCT)

Healthy

Germany
Amgen

Completed

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. (UNVEIL)

Parapsoriasis

United States
Massachusetts General Hospital

Not yet recruiting

Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

Post-operative Pain

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Netherlands, United Kingdom
Novo Nordisk A/S

Completed

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes (UPGRADE)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Oral Manifestations | Graft vs Host Disease

Brazil
Novo Nordisk A/S

Completed

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Wake Forest University Health Sciences
The Skin of Color Society

Recruiting

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study (CCCA)

Central Centrifugal Cicatricial Alopecia (CCCA)

United States
LEO Pharma

Completed

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Canada, Israel
Amgen

Completed

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients (COMMUNITY)

COVID-19

United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
Centre for Human Drug Research, Netherlands
Maruho Co., Ltd.

Completed

Intradermal LPS and Antibiotics

Inflammation; Skin

Netherlands
Icahn School of Medicine at Mount Sinai

Completed

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

Central Centrifugal Cicatricial Alopecia

United States
Hospital Universitari Vall d'Hebron Research Institute
Celgene Corporation

Unknown

Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis (APREMILAST)

Arthritis; Psoriasis (Etiology)
Julian M. Mackay-Wiggan
Celgene Corporation

Completed

Open Label Pilot Study of Apremilast in Treatment of Rosacea

Papulopustular Rosacea | Erythematotelangiectatic Rosacea

United States
Stanford University

Terminated

A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis

Dermatomyositis

United States
Hospital Infantil Albert Sabin

Completed

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Pain, Postoperative | Vomiting | Anesthesia | Agitation States as Acute Reaction to Exceptional Stress

Brazil
Amgen

Completed

A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment (PREVAIL)

Arthritis, Psoriatic

Spain
Amgen

Completed

A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium (OTELO)

Psoriasis

Belgium
Oregon Health and Science University
Celgene Corporation

Terminated

Apremilast in the Treatment of Uveitis

Uveitis

United States
First Hospital of China Medical University
China-Japan Friendship Hospital

Not yet recruiting

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

Psoriasis

China
Florida Academic Dermatology Centers

Completed

Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa

United States
Psoriasis Treatment Center of Central New Jersey
Celgene Corporation

Completed

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Psoriasis

United States
Icahn School of Medicine at Mount Sinai

Completed

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
University of Alabama at Birmingham
Celgene

Completed

An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

Psoriasis | Psoriasis Vulgaris | Psoriatic Nail

United States
Washington University School of Medicine
Celgene Corporation

Completed

A Study Examining the Medication Apremilast as Treatment for Chronic Itch

Itch

United States
Medical University of Graz
Medical University of Vienna; Celgene Corporation; Medical University Innsbruck

Withdrawn

Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast (PSA-ULTRA)

Psoriatic Arthritis

Austria
Derm Research, PLLC
Celgene

Completed

Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy

Plaque Psoriasis

United States
University of Erlangen-Nürnberg Medical School
Celgene Corporation

Completed

Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis

Erosive Osteoarthritis of the Hand

Germany
University of California, San Francisco

Completed

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Chronic Stable Plaque Psoriasis

United States

Search clinical trials for: Apremilast and Clobetasol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations